Cabot Corporation

NYSE:CBT

Chemicals - Specialty

Basic Materials
$74.03 +1.09%

+$0.96 today

Market cap
$3.80B
Beta
0.83
P/E (TTM)
16.3
EPS (TTM)
$5.48
Dividend yield
2.04%
52W Low $58.33High $90.08

Volume 0.53M

Average 0.43M

CBT Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Cabot CorporationNYSE: CBT

Total Equity · Q3 FY2026 · quarter ended Jun 2026

Total equity rises 3.0% from a year ago

Total equity stood at $1.73B at the end of Q3 FY2026, up 3.0% from a year earlier and up 2.8% from the prior quarter. Over 3 fiscal years it compounded at +18.2% a year.

Context

  • Total equity amounted to 43.6% of total assets at the end of Q3 FY2026, down 0.2 pp from a year earlier.
  • Total equity increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps rising in the next quarterly balance sheet after a +3.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.73B+2.8% QoQ
Last fiscal yearSep 2025
$1.71B+7.2% YoY
Year agoJun 2025
$1.68B+3.0% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.0%——
1 year+7.2%——
3-year CAGR+18.2%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
1.71B USD
Year-over-year change
+7.2%
4-year CAGR
+11.8%

Total Equity vs competitors

How CBT compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +3.0% is the 7th highest of 11, against a peer median of +5.2%.
  • Total equity amounts to 43.6% of total assets for CBT, versus a peer median of 40.8%.
CBT Competitors
Total Equity for CBT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SSLSasol LimitedJun 2026ZAR 168.68B ZAR+7.0%-5.8%46.7%
CECelanese CorporationJun 2026$4.59B USD-19.6%-9.9%21.4%
MEOHMethanex CorporationJun 2026$2.87B USD-1.8%+3.9%40.1%
AVNTAvient CorporationSep 2026$2.47B USD+3.4%+0.5%41.6%
FULH.B. Fuller CompanyAug 2026$2.17B USD+10.7%+7.5%39.9%
CBTCabot CorporationJun 2026$1.73B USD+3.0%+18.2%43.6%
KNFKnife River CorporationJun 2026$1.61B USD+9.9%+16.8%38.4%
SXTSensient Technologies CorporationJun 2026$1.26B USD+8.9%+6.1%53.1%
PRMPerimeter Solutions, Inc.Jun 2026$1.02B USD-13.3%-0.2%31.5%
HWKNHawkins, Inc.Sep 2026$563.69M USD+11.2%+15.1%55.7%
WDFCWD-40 CompanyAug 2026$272.97M USD+1.8%+9.1%55.2%
Peer median (excluding CBT) —+5.2%+5.0%40.8%

Competitors are the stored peer set for CBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents168M206M238M223M258M
Short-term Investments00000
Net Receivables645M836M695M733M671M
Inventory523M664M585M552M504M
Other Current Assets00108M0106M
Total Current Assets1.43B1.82B1.63B1.61B1.54B
Property, Plant & Equipment (Net)1.38B1.27B1.41B1.53B1.71B
Goodwill140M129M134M133M134M
Intangible Assets100M63M60M53M55M
Long-term Investments40M20M20M23M16M
Tax Assets53M45M180M216M180M
Other Non-current Assets172M178M172M172M180M
Total Non-current Assets1.88B1.71B1.98B2.13B2.28B
Total Assets3.31B3.53B3.6B3.74B3.82B
Account Payables480M533M438M495M459M
Short-term Debt445M354M182M67M274M
Tax Payables35M44M40M43M35M
Deferred Revenue00000
Other Current Liabilities75M66M55M167M77M
Total Current Liabilities1.15B1.11B822M772M957M
Long-term Debt717M1.09B1.09B1.15B856M
Deferred Tax Liabilities73M65M50M42M39M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities195M151M147M69M173M
Total Non-current Liabilities1.07B1.39B1.38B1.37B1.15B
Total Liabilities2.22B2.49B2.2B2.15B2.11B
Common Stock57M56M55M54M53M
Retained Earnings1.16B1.28B1.57B1.73B1.84B
Accumulated OCI(289M)(439M)(362M)(360M)(335M)
Other Stockholders Equity00000
Minority Interest143M134M143M165M155M
Total Equity1.09B1.03B1.41B1.59B1.71B
Total Debt1.25B1.53B1.36B1.33B1.22B
Net Debt1.08B1.32B1.12B1.11B957M

Cabot Corporation

NYSE:CBT

Intrinsic Alpha fair value

Locked

Current Price

$74.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.